Lymecycline is marketed by the company that became a subsidiary of what multinational in 2014?
a3494d8f454fcef45547b6e92a0366b2
Lymecycline Lymecycline is a tetracycline broad-spectrum antibiotic marketed by the pharmaceutical company Galderma. It is approximately 5,000 times more soluble than tetracycline base and is unique amongst tetracyclines in that it is absorbed by an active transport process across the intestinal wall, making use of the same fast and efficient mechanism by which carbohydrates are absorbed.
9d530111c01685c4293ae6f1521e48cd
Galderma Galderma S.A. is a pharmaceutical subsidiary specializing in the research, development and marketing of dermatological treatments and became a wholly owned subsidiary of Nestlé in 2014.
97862ba6dc205c62859b804b54d6f67b
Krka (company) Krka, d. d., Novo mesto is an international generic pharmaceutical company with headquarters in Novo Mesto, Slovenia. In 2015, Krka Group’s total sales amounted to EUR 1,164.6 million. Over the previous five years, average annual sales growth had been 2.9 %. Krka’s was selling products to more than 70 countries. As well as a number of companies and representative offices abroad, Krka also had production and distribution centres in the Russian Federation, Poland, Croatia and Germany. At the end of March 2015, Krka employed 10,564.
758d979588ee460b3b49b8798805dfdf
Eurogentec Eurogentec is an international biotechnology supplier, based in Belgium, that specializes in genomics and proteomics kits and reagents as well as cGMP biologics. The company was founded in 1985 as a spin-off from the University of Liège. Eurogentec's contract manufacturing organization facilities are licensed by the Belgian Ministry of Health to produce clinical trial and commercial biopharmaceutical material and also licensed by the US FDA to manufacture a commercial recombinant protein product for the US market. Eurogentec operates two manufacturing facilities in Belgium that provide custom biologics and oligonucleotide-based components for diagnostic and therapeutic applications.
cebca713f43f9e15537f58adfc420400
Tigecycline Tigecycline is an antibiotic used to treat a number of bacterial infections. It is a glycylcycline that is administered intravenously. It was developed in response to the growing rate of antibiotic resistance in bacteria such as "Staphylococcus aureus", "Acinetobacter baumannii", and "E. coli". As a tetracycline derivative antibiotic, its structural modifications has expanded its therapeutic activity to include Gram-positive and Gram-negative organisms, including those of multi-drug resistance.
fd0e49ff8dfeb236bd0b7eaf207df511
OM Group OM Group Incorporated is a metal-based chemistry firm based in Cleveland, Ohio, United States. It is a provider of speciality chemicals, advanced materials and technologies. The company was listed on the New York Stock Exchange prior to being privatized by Apollo Global Management in June 2015.
ab5421e0dfc73228ffdf8de7d85e5c37
Medtronic Medtronic Public Limited Company is a medical device company. Its headquarters are in Dublin, Ireland. Its operational headquarters are in Fridley, Minnesota. Medtronic is the world's largest standalone medical equipment development company.
fb602f5c61c395b3d1a289129a0a4dda
Perrigo Perrigo Company plc is an American international manufacturer of private label over-the-counter pharmaceuticals. The company’s shares are traded on the NYSE and the Tel Aviv Stock Exchange; as a result of the merger with Agis Industries the company is a constituent of the TA-25 Index. Perrigo is the only non-Israeli company on the TA-25.
1d604bc450329c36e40bff35cfb828d8
Synthes Synthes Holding AG (formerly Synthes-Stratec) is a multinational medical device manufacturer based in Solothurn, Switzerland and West Chester, Pennsylvania, United States. It is the world's largest maker of implants to mend bone fractures, and also produces surgical power tools and advanced biomaterials.
9865f17f486d8aa672f8229e2aa58df6
Chugai Pharmaceutical Co. Chugai Pharmaceutical Co., Ltd. (中外製薬株式会社 , Chūgai Seiyaku Kabushikigaisha ) is a subsidiary drug manufacturer operating in Japan controlled by Hoffmann–La Roche, which owns 62% of the company as of 30 June 2014. Previous to Roche's takeover in 2002, Chugai was a pioneering discoverer of many important pharmaceutical compounds. The company is headquartered in Tokyo. Osamu Nagayama is the current representative director, chairman, and CEO. Tatsuro Kosaka is the current representative director, president, and COO.
012fd76af4468ed68e2a8ddaf986e165
G.D. Searle, LLC G.D. Searle, LLC is a wholly owned trademark of Pfizer. It is currently used mainly as a distribution trademark for various pharmaceuticals that were developed by G. D. Searle & Company (often referred to as Searle). Prior to its 1985 merger with Monsanto, Searle was a company focusing on life sciences, specifically pharmaceuticals, agriculture, and animal health.
0f923b4f2eab7a3ea3225a1a9cff23c6
Unilever Nepal Unilever Nepal Limited (UNL); (Nepali: युनिलिभर नेपाल लिमिटेड ) formerly Nepal Lever Limited is the Nepali subsidiary company of Anglo-Dutch FMCG company Unilever. Its products include foods,beverages, cleaning agents and personal care products. Nepal lever is one of the largest personal care company in South Asia.
6c92565d039428f5c1f5f873b34ad0d8
Genentech Genentech, Inc., is a biotechnology corporation which became a subsidiary of Roche in 2009. Genentech Research and Early Development operates as an independent center within Roche.
d81dd8343c2cdef806336d24337bd0c7
Millennium Pharmaceuticals Millennium Pharmaceuticals, Inc., The Takeda Oncology Company was a leading biopharmaceutical company based in Cambridge, Massachusetts. Millennium has gradually been absorbed by its parent Takeda and renamed Takeda Oncology. The Company marketed Velcade (bortezomib) for injection, a cancer product, and has a growing clinical development pipeline of product candidates. Millennium's research, development and commercialization activities focused in two therapeutic areas: oncology and inflammation. By applying its knowledge of the human genome, understanding of disease mechanisms and industrialized drug discovery platform, Millennium developed a line of new product candidates. It was one of the first companies to systematically search for genes linked to disease, but none of the drugs which it is marketing or has in clinical trial, with one partial exception, have been the results of that research. On May 14, 2008, Japanese company Takeda Pharmaceutical announced the completion of its acquisition of Millennium for US$25.00 per share in cash—a deal worth $8.8 billion. Takeda completed the acquisition through a tender offer and subsequent merger of a wholly owned subsidiary of Takeda into Millennium. Millennium is now a wholly owned subsidiary of Takeda.
180be6ae34a7d55a6573de5be65090ee
Harbin Pharmaceutical Group Harbin Pharmaceutical Group Co., Ltd. () is China's second-biggest drug maker by market value. The major shareholder of the company was for 47.06% stake (as at 30 June 2016), literally have the same English name with the listed subsidiary, as the listed subsidiary missed the word "Joint-Stock / Shares" () in its English official name.
4ba5a82d348fe3f6d6e7535d863442fe
Loghman Pharmaceuticals Loghman Pharmaceutical & Hygienic Co. (Persian: شرکت دارویی و بهداشتی لقمان‎ ‎ ) is an Iranian pharmaceuticals company. The company engages in the discovery, development, manufacture, and marketing of health care solutions in Iran.
b36724137d9f64386a4ff078a03aded7
Intarcia Therapeutics Intarcia Therapeutics is an American biopharmaceutical company based in Boston, MA and incorporated under the laws of Delaware. It was founded in 1995 under the name "BioMedicines" and changed to its present name in 2004. In 2013, Intarcia relocated its headquarters to Boston, keeping its manufacturing facility in Hayward, CA. In addition to Boston and Hayward, Intarcia also has a location in Research Triangle Park, North Carolina, where it discovers and develops peptides for its drug delivery system.
3626c3a0fe73208a6bb2b860d301b65b
Vedolizumab Vedolizumab (trade name Entyvio) is a monoclonal antibody developed by Millennium Pharmaceuticals, Inc (a subsidiary of Takeda Pharmaceuticals) for the treatment of ulcerative colitis and Crohn's disease. It binds to integrin αβ (LPAM-1, lymphocyte Peyer's patch adhesion molecule 1). Blocking the αβ integrin results in gut-selective anti-inflammatory activity. It is marketed under the trade name Entyvio.
cbea63edf6a43ce01baa6219d3521aee
Brioschi (company) Brioschi is an Italian company founded in 1907 as "Achille Brioschi & C." to "produce and make commerce of chemicals, liquors and similars"; in 1914 the society was quoted on the Milan stock exchange. In the 1970s Brioschi was transformed into an investment company and today’s Brioschi Sviluppo Immobiliare is a real estate contractor, no longer bearing any relationship to the epoch-making "cachet Brioschi" which was once its staple product. Its offshoot, the American company Brioschi Pharmaceuticals, LLC, continued to market the effervescent antacid in the United States, however in 2013 Brioschi Pharmaceuticals LLC filed for bankruptcy and discontinued selling Brioschi products in North America. That was until 2015 when the Canadian company Neobourne Pharma LP. obtained control of the Brioschi Brand and trademark for North America. Neobourne Pharma is now marketing and selling the effervescent antacid in the United States and in Canada.
09db807d06edade614e99aeeb347605a
Mercuria Energy Group Mercuria Energy Group Ltd is a privately held Swiss international commodity trading company active over a wide spectrum of global energy markets including crude oil and refined petroleum products, natural gas (including LNG), power, coal, biodiesel, carbon emissions, base metals and agricultural products. In 2014, the company bought the commodities trading arm of J.P. Morgan in a reported US$800 million deal.
cd9ad26a206c4a928a1bd83adc06e1fe
Romat Romat (Cyrillic:Ромат) is a pharmaceutical company and Kazakhstan's leading pharmaceutical brand.
b49ae2c964a278f8d98a3cf98195de6b
Total S.A. Total S.A. (] ; or ) is a French multinational integrated oil and gas company and one of the seven "Supermajor" oil companies in the world. Its businesses cover the entire oil and gas chain, from crude oil and natural gas exploration and production to power generation, transportation, refining, petroleum product marketing, and international crude oil and product trading.